ATE459644T1 - Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung - Google Patents

Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung

Info

Publication number
ATE459644T1
ATE459644T1 AT03763948T AT03763948T ATE459644T1 AT E459644 T1 ATE459644 T1 AT E459644T1 AT 03763948 T AT03763948 T AT 03763948T AT 03763948 T AT03763948 T AT 03763948T AT E459644 T1 ATE459644 T1 AT E459644T1
Authority
AT
Austria
Prior art keywords
seq
cosmetics
areas
treatment
aspartic proteases
Prior art date
Application number
AT03763948T
Other languages
English (en)
Inventor
Dominique Bernard
Bruno Mehul
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE459644T1 publication Critical patent/ATE459644T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03763948T 2002-07-09 2003-07-09 Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung ATE459644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0208613A FR2842209B1 (fr) 2002-07-09 2002-07-09 Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
PCT/FR2003/002151 WO2004007548A1 (fr) 2002-07-09 2003-07-09 Utilisation de proteases aspartiques dans le domaine cosmetique et therapeutique

Publications (1)

Publication Number Publication Date
ATE459644T1 true ATE459644T1 (de) 2010-03-15

Family

ID=29763673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03763948T ATE459644T1 (de) 2002-07-09 2003-07-09 Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung

Country Status (10)

Country Link
US (2) US7521422B2 (de)
EP (1) EP1519952B1 (de)
JP (1) JP4459808B2 (de)
AT (1) ATE459644T1 (de)
AU (1) AU2003264708A1 (de)
CA (1) CA2491080A1 (de)
DE (1) DE60331546D1 (de)
ES (1) ES2340481T3 (de)
FR (1) FR2842209B1 (de)
WO (1) WO2004007548A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842209B1 (fr) * 2002-07-09 2007-11-23 Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
KR101165848B1 (ko) * 2005-08-18 2012-07-13 (주)아모레퍼시픽 효소 및 아미노산을 함유하는 피부 화장료 조성물
JP5274015B2 (ja) * 2005-10-11 2013-08-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 サスペースノックアウト動物
EP2249853A4 (de) 2008-01-30 2012-12-26 Univ Indiana Res & Tech Corp Peptid-prodrugs auf esterbasis
AU2009327418A1 (en) 2008-12-19 2010-06-24 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
CN102245624B (zh) * 2008-12-19 2016-08-10 印第安纳大学研究及科技有限公司 基于酰胺的胰岛素前药
KR20110114568A (ko) * 2008-12-19 2011-10-19 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 디펩티드 링크된 약효 물질
WO2010080606A1 (en) 2008-12-19 2010-07-15 Indiana University Research And Technology Corporation Insulin analogs
US20110076333A1 (en) * 2009-09-25 2011-03-31 Susan Daly Method and compositions for selectively treating skin
WO2011159895A2 (en) 2010-06-16 2011-12-22 Indiana University Research And Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
US8946147B2 (en) 2010-06-24 2015-02-03 Indiana University Research And Technology Corporation Amide-based insulin prodrugs
EP2588126A4 (de) 2010-06-24 2015-07-08 Univ Indiana Res & Tech Corp Amidbasierte glucagon-superfamilien-peptid-prodrugs
FR2968201B1 (fr) * 2010-12-07 2017-07-21 Oreal Complexe saspase-flg2, agents modulateurs et utilisations
FR2968200B1 (fr) * 2010-12-07 2013-01-18 Oreal Agents modulateurs du complexe saspase-flg2 et utilisations
FR2968303B1 (fr) 2010-12-07 2013-01-18 Oreal Peptides modulateurs du complexe saspase-flg2
FR2968199B1 (fr) * 2010-12-07 2013-01-18 Oreal Agents modulateurs du complexe saspase-flg2 et peaux grasses
US9573987B2 (en) 2011-12-20 2017-02-21 Indiana University Research And Technology Corporation CTP-based insulin analogs for treatment of diabetes
FR2991680B1 (fr) * 2012-06-06 2014-09-05 Oreal Composes pour application anti-age et peau seche
CN108383902A (zh) 2012-09-26 2018-08-10 印第安纳大学研究及科技有限公司 胰岛素类似物二聚体
WO2014158900A1 (en) 2013-03-14 2014-10-02 Indiana University Research And Technology Corporation Insulin-incretin conjugates
GB201305023D0 (en) 2013-03-19 2013-05-01 Biocant Associa O De Transfer Ncia De Tecnologia Aspartic proteases
ES2822994T3 (es) 2014-09-24 2021-05-05 Univ Indiana Res & Tech Corp Conjugados de incretina-insulina
EP3197912B1 (de) 2014-09-24 2023-01-04 Indiana University Research & Technology Corporation Lipdierte amidbasierte insulin-prodrugs
ES3055661T3 (en) 2016-08-23 2026-02-13 Sytheon Ltd Compositions comprising isohexide diesters of c18 fatty acids and their use in methods for restoring epidermal integrity and function and treating dermatological diseases
CA3067363A1 (en) * 2017-07-17 2019-01-24 Universite Laval Asprv1 as a neutrophil-specific marker and therapeutic target for inflammatory diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9319104D0 (en) * 1993-09-15 1993-11-03 Unilever Plc Skin care method & composition
FR2761363B1 (fr) 1997-03-28 1999-11-26 Oreal Polypeptide purifie de l'epiderme et son utilisation
FR2767833B1 (fr) 1997-08-29 2001-03-02 Oreal Polypeptide isole de l'epiderme et son utilisation
DE19950020A1 (de) 1999-10-16 2001-04-19 Henkel Kgaa Verwendung von Zusammensetzungen zur pflegenden Behandlung der Haut
GB0004312D0 (en) 2000-02-23 2000-04-12 Oxagen Limited Test and model for inflammatory disease
US20030206896A1 (en) 2000-09-13 2003-11-06 O'prey Conor James Cosmetic method
AU2000274825A1 (en) 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic method
JP2003088388A (ja) * 2001-09-14 2003-03-25 Herikkusu Kenkyusho:Kk 新規な全長ｃＤＮＡ
FR2842209B1 (fr) * 2002-07-09 2007-11-23 Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique

Also Published As

Publication number Publication date
DE60331546D1 (de) 2010-04-15
US7888315B2 (en) 2011-02-15
WO2004007548A1 (fr) 2004-01-22
ES2340481T3 (es) 2010-06-04
JP4459808B2 (ja) 2010-04-28
US20060240053A1 (en) 2006-10-26
AU2003264708A1 (en) 2004-02-02
US20090186821A1 (en) 2009-07-23
CA2491080A1 (fr) 2004-01-22
EP1519952A1 (de) 2005-04-06
FR2842209B1 (fr) 2007-11-23
EP1519952B1 (de) 2010-03-03
FR2842209A1 (fr) 2004-01-16
JP2006511204A (ja) 2006-04-06
US7521422B2 (en) 2009-04-21

Similar Documents

Publication Publication Date Title
ATE459644T1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
ATE333888T1 (de) Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
ATE386538T1 (de) Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden
DE69938786D1 (de) Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe
EA200200755A1 (ru) Опосредованная рецептором nogo блокада роста аксонов
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
YU5396A (sh) Novi biološki aktivni proteini, njihove farmaceutske formulacije i postupak za njihovo dobijanje
EP1594889A4 (de) Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DE69823935D1 (de) Aus dem Epidermis isolierte Polypeptide und Verwendung davon
DE69412243D1 (de) Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
DE69427650D1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
ATE411811T1 (de) Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie
DE60045681D1 (de) Vaskuläre adhesionsmoleküle und modulierung ihrer funktion
ATE363531T1 (de) Claudin polypeptide
YU79202A (sh) Peptid koji modulira trombopoetinski receptor
ATE364079T1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
ATE407947T1 (de) Proteine mit il-6 inhibitorischer wirkung
ATE438658T1 (de) Neue polypeptide aus bienengift und dessen gebrauchsverfahren
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
HUP9900789A2 (hu) Lefelé irányuló szabályozásra rezisztens C3 konvertáz
DE60135489D1 (de) Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties